newsfilter
← Latest News
GlobeNewswire·

VYNE Reports First Quarter 2024 Financial Results and Provides Business Update

Design of Phase 2b trial for VYN201 in nonsegmental vitiligo finalized and on track to begin this quarterPhase 2b trial expected to enroll approximately 160 subjects with either active or stable nonsegmental vitiligo and